BELLANTI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 5.734
NA - Nord America 4.634
AS - Asia 3.699
SA - Sud America 474
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 7
Totale 14.619
Nazione #
US - Stati Uniti d'America 4.541
IE - Irlanda 1.355
SG - Singapore 1.307
CN - Cina 1.298
IT - Italia 1.243
UA - Ucraina 810
SE - Svezia 729
RU - Federazione Russa 422
BR - Brasile 411
HK - Hong Kong 359
DE - Germania 336
FI - Finlandia 236
IN - India 206
FR - Francia 200
VN - Vietnam 176
TR - Turchia 169
GB - Regno Unito 130
AT - Austria 78
CA - Canada 54
BE - Belgio 33
ES - Italia 31
CZ - Repubblica Ceca 28
MX - Messico 28
BD - Bangladesh 27
PL - Polonia 25
AR - Argentina 21
ID - Indonesia 21
IQ - Iraq 20
NL - Olanda 20
AE - Emirati Arabi Uniti 19
EU - Europa 18
ZA - Sudafrica 18
JP - Giappone 17
CH - Svizzera 13
IR - Iran 11
EC - Ecuador 10
KR - Corea 10
VE - Venezuela 10
LT - Lituania 8
AL - Albania 7
CO - Colombia 7
PK - Pakistan 7
RO - Romania 7
UZ - Uzbekistan 7
CL - Cile 6
IL - Israele 6
KE - Kenya 6
SA - Arabia Saudita 6
EG - Egitto 5
KZ - Kazakistan 5
MA - Marocco 5
PH - Filippine 5
TN - Tunisia 5
LV - Lettonia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
AU - Australia 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
JO - Giordania 3
PY - Paraguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GR - Grecia 2
JM - Giamaica 2
NP - Nepal 2
PE - Perù 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
GE - Georgia 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RE - Reunion 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 14.615
Città #
Dublin 1.355
Singapore 669
Chandler 647
Jacksonville 552
Nyköping 482
Hong Kong 352
Dearborn 342
Ashburn 293
Beijing 277
Dallas 269
Nanjing 238
Santa Clara 202
Wilmington 152
New York 133
Princeton 133
Nanchang 114
Munich 109
Helsinki 104
San Mateo 95
Moscow 93
Ann Arbor 91
Rome 88
The Dalles 88
Ho Chi Minh City 81
Vienna 72
Boardman 70
Milan 66
Shenyang 64
Bari 61
Foggia 57
Woodbridge 54
Tianjin 53
Kunming 46
Los Angeles 46
Hebei 41
Turku 41
Jiaxing 36
São Paulo 35
Des Moines 34
Brussels 33
Changsha 32
Hangzhou 32
Hanoi 30
Jinan 30
Stevenage 27
Houston 26
Delhi 24
Redwood City 24
Shanghai 24
Toronto 24
Zhengzhou 23
Ningbo 22
Seattle 22
Brno 20
Guangzhou 20
Naples 20
Hilden 19
London 18
Pune 17
Rio de Janeiro 17
Assago 16
Frankfurt am Main 16
San Francisco 16
Brooklyn 15
Tokyo 15
Jakarta 14
Norwalk 14
Palermo 14
Bologna 13
Caserta 13
Mola Di Bari 13
Fuzhou 12
Wuhan 12
Barcelona 11
Belo Horizonte 11
Chicago 11
San Severo 11
Kraków 10
Orange 10
Padova 10
Taizhou 10
Warsaw 10
Augusta 9
Charlotte 9
Council Bluffs 9
Florence 9
Montreal 9
Stockholm 9
Atlanta 8
Auburn Hills 8
Boston 8
Cedar Knolls 8
Changchun 8
Falkenstein 8
Napoli 8
Paris 8
Alcamo 7
Ankara 7
Baghdad 7
Campinas 7
Totale 8.662
Nome #
Effetti della sarcopenia e dell’obesità sarcopenica sul rischio cardiovascolare 765
Effetti dell’associazione tra malnutrizione e sarcopenia sulla composizione corporea 240
A silybin-phospholipid vitamin E complex (siliphos) limits the hepatic damage and reduces oxidative stress in human obesity – related liver disease. 183
Aging e disaccoppiamento mitocondriale: diverso effetto sulla produzione di radicali liberi in tessuti mitotici e post-mitotici. 176
A silybin-phospholipid-vitamin E complex (SILIPHOS) prevents oxidation of UCP2 and limits mitochondrial dysfunction during non-alcoholic steatohepatitis. 171
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 164
Effetti del diabete mellito tipo 2 sulla composizione corporea dei pazienti sarcopenici 151
Disaccoppiamento mitocondriale in corso di Steatoepatite Non Alcolica 149
Alteration of fatty acid beta-oxidation observed in severe steatosis depends on CPT1 impairment and change in mitochondrial membrane lipid composition. 146
Aging e disaccoppiamento mitocondriale: diverso effetto sulla produzione di radicali liberi in tessuti mitotici e post-mitotici. 145
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 139
A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis 138
Adherence to Mediterranean Diet, Malnutrition, Length of Stay and Mortality in Elderly Patients Hospitalized in Internal Medicine Wards 138
Meccanismi del danno ed effetti protettivi di exenatide in un modello sperimentale di ischemia/riperfusione cerebrale 137
Il complesso silibina-fosfolipidi-vitamina E normalizza l’ipertransaminasemia in soggetti affetti da steatosi epatica non alcolica. 135
Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model 130
A Silybin-phospholipid Complex Prevents Mitochondrial Oxidative Stress in Models of Chronic Liver Disease. 127
A silybin-phospholipids-vitamin E complex (siliphos) reduces oxidative stress in patients affected by non-alcoholic hepatic steatosis. 127
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 127
UCP2 overexpression sensitizes NASH liver to ischemia/reperfusion injury by increasing mitochondrial proton leak. 126
Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity (Q1 WoS) 126
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 125
Disaccoppiamento mitocondriale in corso di Steatoepatite Non Alcolica 124
A silybin-phospholipid-vitamin E complex reduces mitochondrial oxidative stress in a rodent model of chronic cholestasis. 123
Oxidative stress and aging. 122
Exenatide e gli inibitori di DPP-4 sono efficaci nel trattamento della neuropatia sensitiva associata a diabete mellito tipo II in pazienti anziani 120
Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury 119
N-acetylcysteine prevents amiodarone-induced inhibition of Complex I, OXPHOS uncoupling and cardiolipin peroxidation in rat liver mitochondria. 119
Alterazioni bioenergetiche mitocondriali durante lo sviluppo della Steatoepatite Non Alcolica 117
CPT-1 is a key target of mitochondria nitrosylation during NASH development 117
Analisi della bioenergetica mitocondriale in corso di Ischemia/Riperfusione renale e ruolo protettivo del postcondizionamento ischemico. 117
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 116
Mitochondria peroxide synthesis and CPT-1 nitrosylation durino NASH development: a model of oxidative stress disease 115
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 114
Il postcondizionamento renale protegge il rene dal danno da ischemia riperfusione attraverso l’inibizione del mitchondrial permeabilità transitino pore. 112
La supplementazione di silibina e vitamina E (silyphos) previene la disfunzione mitocondriale osservata nella steatoepatite non alcolica. 112
Oxidation of Carnitine Palmitoyl Transferase 1 alters fatty acid metabolism in a rodent model of nonalcoholic steatohepatitis. 111
UCP2 induces mitochondrial uncoupling during nonalcoholic steatohepatitis: An adaptative mechanism to reduce oxidative stress but producing depletion of ATP 111
Disfunzione mitocondriale in differenti aree cerebrali in un modello transgenico di Alzheimer. 111
Lo stress ossidativo e la disfunzione mitocondriale nella NASH causano l’attivazione del PTP inducendo l’apoptosi. 111
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 111
Mitochondrial Oxidative Stress is an Early Event in Amiodarone Hepatotoxicity, Inducing Complex I Impairment and Cardiolipin Peroxidation. 110
Bioenergetics in aging: mitochondrial proton leak in aging rat liver, kidney and heart 110
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 110
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 110
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 109
Alterazioni della bioenergetica mitocondriale in un modello animale di ipoperfusione cerebrale cronica. 108
Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet. 108
UCP2 increase the sensibilità to liver ischemia/reperfusion injury in a NASH model. 108
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 108
Polimorfismi del gene della Glutatione S-Trasferasi Omega -1: analisi del linkage disequilibrium fra i polimorfismi Ala140Asp E Glu155ΔGlu dell’esone 4 e interazione con l’ApoE in una popolazione di centenari pugliesi 107
Lo stress ossidativo e la disfunzione mitocondriale nella NASH causano l’attivazione del PTP inducendo l’apoptosi. 105
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 105
A myoferlin gain-of-function variant associates with a new type of hereditary angioedema 105
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 104
Nella steatoepatite indotta da amiodarone le alterazioni della funzione mitocondriale precedono la steatosi e la necrosi e suggeriscono nuove strategie di intervento terapeutico. 103
UCP2 increase the sensibility to liver ischemia/reperfusion injury in a NASH model. 103
Reactive Oxygen Species (ROS) and liver disease therapy 103
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 102
Cerebral oligoemia induces mitochondria dysfunction and increase in hydroperoxide production in a chronic rat model of vascular dementia. 101
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 101
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 100
Oxysterols in the orchestra of liver cell metabolism 99
Propofol but not sevoflurane prevents mitochondrial dysfunction and oxidative stress by limiting HIF-1α activation in hepatic ischemia/reperfusion injury (Q1 WoS) 99
Oxidative stress and mitochondrial dysfunction are associated with the opening of permeability transition pore in a rodent model of NAFLD. 98
Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease 97
Studio delle alterazioni comportamentali e istologiche in un modello animale di oligoemia cerebrale cronica. 96
Changes in circulating redox bilance and increased markers of oxidative stress predict Frailty condition: the “Oxidative Frailty Syndrome”. 96
Mitochondrial involvement in non-alcoholic steatohepatitis 95
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 94
NASH induces expression of UCP2 and mitochondria respiratory impairment in liver hepatocytes 93
Rat brain bioenergetics is impaired in a two-vessel occlusion model of vascular dementia. 93
Disfunzione mitocondriale in differenti aree cerebrali di ratti senescenti: importanza dell'assessment bioenergetico. 93
Treatment of chronic HCV infection in the era of protease inhibitors 93
Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients (Q1 WoS) 93
Comparison of Three Nutritional Screening Tools with the New Glim Criteria for Malnutrition and Association with Sarcopenia in Hospitalized Older Patients 91
Malnutrition in Hospitalized Old Patients: Screening and Diagnosis, Clinical Outcomes, and Management 90
Mitochondrial activity in NASH pathogenesis: role of respiratory chain and fatty acids transport 89
Mitochondrial proton leak during aging: ditferent effect on free radicals production in mitotic and postmitotic tissues. 89
Disfunzione mitocondriale in differenti aree cerebrali di ratti senescenti: importanza dell’assessment bioenergetico. 88
Blood Magnesium Level and Selected Oxidative Stress Indices in Lead-Exposed Workers 88
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 87
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation (Q1 WoS) 87
Changes in circulating redox balance and increased markers of oxidative stress predict Frailty condition: the "Oxidative Frailty Syndrome'' 87
PROPOFOL, BUT NOT SEVORANE, PROTECTS MITOCHONDRIA AND LIVER FUNCTION AFTER ISCHEMIA-RIPERFUSION INJURY 85
PROPOFOL, BUT NOT SEVORANE, PROTECTS MITOCHONDRIA AND LIVER FUNCTION AFTER ISCHEMIA-REPERFUSION INJURY 84
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 82
HNE induces UCP2 expression and proton leak to limit oxidative stress but reduces ATP synthesis in non-alcoholic steatohepatitis. 81
Free radical biology for medicine: learning from nonalcoholic fatty liver disease. 81
Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress 80
Ischemia-reperfusion injury: evidences for translational research 80
Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. 80
Mitochondrial dysfunction in nonalcoholic steatohepatitis. 80
Targeting Mitochondria: a new promising approach for the treatment of liver diseases 79
Effect of sevoflurane and propofol anaesthesia on mitochondria and postoperative hepatocellular injury in steatotic patients: preliminary data: 9AP5‐7 78
Reliability of serum procalcitonin concentration for the diagnosis of sepsis in elderly patient with chronic kidney disease 78
Renal postconditioning: a novel mechanism in the prevention of I/R damage. 77
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 77
La supplementazione di silibina e vitamina E (silyphos) previene la disfunzione mitocondriale osservata nella steatoepatite non alcolica. 77
Impact of Nutritional Status on Muscle Architecture in Elderly Patients Hospitalized in Internal Medicine Wards 76
Totale 11.597
Categoria #
all - tutte 82.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021699 0 0 0 0 0 39 154 96 178 186 12 34
2021/20221.030 119 12 23 16 98 40 51 110 123 102 83 253
2022/20233.270 331 171 151 157 176 280 40 265 1.501 35 65 98
2023/2024807 96 44 38 47 47 213 29 43 13 18 56 163
2024/20252.905 161 76 122 134 130 350 293 138 680 188 311 322
2025/20262.399 353 357 586 624 353 126 0 0 0 0 0 0
Totale 15.262